Почетна › Рак на бели дробови со не-мали клетки › Вирџинија › Arlington
Клинички испитувања за Рак на бели дробови со не-мали клетки во Arlington, VA
104 студии за Рак на бели дробови со не-мали клетки бараат учесници на локации во и околу Arlington (во радиус од околу 30 милји). Отворете ја студијата за да видите кој може да учествува и како да го контактирате тимот.
Официјален текст на студијата (англиски)
Барате учесници за студија? Истакнете ја на врвот од оваа страница — $99 за 30 дена →
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Се регрутираФаза 2
- Virginia Cancer Specialists - Fairfax /ID# 272004, Fairfax · на 11 милји
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Се регрутираФаза 3
- Kaiser Permanente Tysons Corner Medical Center, McLean · на 5 милји
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Се регрутираФаза 1
- Inova Schar Cancer Institute, Fairfax · на 11 милји
- NEXT Virginia, Fairfax · на 11 милји
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Се регрутираФаза 1/2
- Virginia Cancer Specialists, Fairfax · на 11 милји
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
Се регрутираФаза 3
- Virginia Cancer Specialists ( Site 0167), Fairfax · на 11 милји
A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.
Се регрутираФаза 2/3
- Virginia Cancer Specialists, PC, Fairfax · на 11 милји
A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015)
Се регрутираФаза 3
- Virginia Cancer Specialists ( Site 0114), Fairfax · на 11 милји
A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
Се регрутираФаза 1
- Site 04, Fairfax · на 11 милји
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung Cancer
Се регрутираФаза 2
- Virginia Cancer Specialists, Fairfax · на 11 милји
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
Се регрутираФаза 1
- ALX Center 2, Fairfax · на 11 милји
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Се регрутираФаза 3
- Virginia Cancer Specialists, Fairfax · на 11 милји
A Study of PHN-012 in Patients With Advanced Solid Tumors
Се регрутираФаза 1
- PHN-012-001 Site, Fairfax · на 11 милји
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Се регрутираФаза 3
- Virginia Cancer Specialists, Fairfax · на 11 милји
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
Се регрутираФаза 2
- Virginia Cancer Specialists, Fairfax · на 11 милји
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Се регрутираФаза 2
- Virginia Cancer Specialists, Fairfax · на 11 милји
A Study of Amivantamab and Olomorasib Combination Therapy in Participants With Metastatic Non-Small Cell Lung Cancer
Се регрутираФаза 1/2
- Virginia Cancer Specialists, Fairfax · на 11 милји
A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)
Се регрутираФаза 1
- Virginia Cancer Specialists PC, Fairfax · на 11 милји
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
Се регрутираФаза 2
- Research Site, Fairfax · на 11 милји
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
Се регрутираФаза 2/3
- Virginia Cancer Specialists - Arlington, Arlington
- Virginia Cancer Specialists, Fairfax · на 11 милји
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
Се регрутираФаза 1/2
- Inova Schar Cancer Institute Clinical Trials, Fairfax · на 11 милји
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Се регрутираФаза 1/2
- NEXT Oncology Virginia, Fairfax · на 11 милји
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Се регрутираФаза 1
- Virginia Cancer Specialists, Fairfax · на 11 милји
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
Се регрутираФаза 1/2
- Next Oncology Virginia Cancer Specialist, Fairfax · на 11 милји
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Се регрутираФаза 3
- Research Site, Fairfax · на 11 милји
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
Се регрутираФаза 3
- Clinical Study Site, Fairfax · на 11 милји
A Study to Compare Setidegrasib (ASP3082) With Docetaxel, in People With Non-small Cell Lung Cancer With a KRAS G12D Mutation
Се регрутираФаза 3
- Virginia Cancer Specialists, Arlington
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
Се регрутираФаза 3
- Virginia Cancer Specialists, PC, Fairfax · на 11 милји
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
Се регрутираФаза 1
- NEXT - Virginia, Fairfax · на 11 милји
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Се регрутираФаза 1/2
- NEXT Virginia, Fairfax · на 11 милји
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Се регрутираФаза 2/3
- Local Institution - 007-814-D, Arlington
- USOR - Virginia Cancer Specialists - Fairfax Office, Fairfax · на 11 милји
Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib
Се регрутираФаза 1/2
- Virginia Cancer Specialists, Fairfax · на 11 милји
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
Се регрутираФаза 1/2
- Inova Schar Cancer Institute, Fairfax · на 11 милји
- Next Oncology Virginia, Fairfax · на 11 милји
A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)
Се регрутираФаза 2
- Virginia Cancer Specialists (Fairfax) - USOR, Fairfax · на 11 милји
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Се регрутираФаза 1
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · на 11 милји
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
Се регрутираФаза 1
- USO-Virginia Cancer Specialists, PC, Fairfax · на 11 милји
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Се регрутираФаза 3
- USO - Virginia Cancer Specialists, Fairfax · на 11 милји
A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors
Се регрутираФаза 1
- NEXT Oncology Virginia, Fairfax · на 11 милји
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
Се регрутираФаза 3
- Research Site, Fairfax · на 11 милји
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
Се регрутираФаза 1
- NEXT Oncology, Fairfax · на 11 милји
First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR or HER2 Exon 20 Insertion Mutations
Се регрутираФаза 1/2
- NEXT Virginia, Fairfax · на 11 милји
A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors
Се регрутираФаза 1/2
- NEXT Virginia, Fairfax · на 11 милји
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
Се регрутираФаза 1
- Virginia Cancer Specialists, PC, Fairfax · на 11 милји
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
Се регрутираФаза 1
- Virginia Cancer Specialists, Fairfax · на 11 милји
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
Се регрутираФаза 3
- Virginia Cancer Specialists, Fairfax · на 11 милји
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
Се регрутираФаза 1
- NEXT Virginia, Fairfax · на 11 милји
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
Се регрутираФаза 3
- Research Site, Fairfax · на 11 милји
Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer
Се регрутираФаза 2
- Virginia Cancer Specialists, Fairfax · на 11 милји
A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
Се регрутираФаза 1/2
- Virginia Cancer Specialists, Fairfax · на 11 милји
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
Се регрутираФаза 1
- Inova Schar Cancer Institute, Falls Church · на 4 милји
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
Се регрутираФаза 1/2
- Research Site, Fairfax · на 11 милји
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Се регрутираФаза 3
- Inova Schar Cancer Institute, Fairfax · на 11 милји
- Inova Fair Oaks Hospital, Fairfax · на 11 милји
A Study of DM005 in Patients With Advanced Solid Tumors
Се регрутираФаза 1/2
- NEXT Oncology Virginia, Fairfax · на 11 милји
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
Се регрутираФаза 1/2
- Clinical Trial Site, Fairfax · на 11 милји
A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)
Се регрутираФаза 1/2
- NEXT Virginia, Fairfax · на 11 милји
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations
Се регрутираФаза 1/2
- NEXT Virginia, Fairfax · на 11 милји
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
Се регрутираФаза 1
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · на 11 милји
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Се регрутираФаза 1/2
- USOR Virginia Cancer Specialists, Fairfax · на 11 милји
Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
Се регрутираФаза 1/2
- NEXT Virginia, Fairfax · на 11 милји
AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
Се регрутираФаза 1
- Next Virginia, Fairfax · на 11 милји
Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint In
Се регрутираФаза 3
- Virginia Cancer Specialists, Fairfax · на 11 милји
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Се регрутираФаза 1
- NEXT Virginia, Fairfax · на 11 милји
Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancer
Се регрутираФаза 1
- NEXT Virginia, Fairfax · на 11 милји
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
Се регрутираФаза 1/2
- NEXT Virginia, Fairfax · на 11 милји
Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer
Се регрутираФаза 1
- NEXT Virginia, Fairfax · на 11 милји
A Study to Investigate ANS02 in Participants With EGFR Mutation-Positive Non-Small Cell Lung Cancer
Се регрутираФаза 1/2
- Research Site, Fairfax · на 11 милји
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Се регрутираФаза 1
- Virginia Cancer Specialists, Fairfax · на 11 милји
A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors
Се регрутираФаза 1
- NEXT Virginia, Fairfax · на 11 милји
A Study of Novel Combinations in Non-Small Cell Lung Cancer (NSCLC)
Се регрутираФаза 2
- Research Site, Fairfax · на 11 милји
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Се регрутираФаза 1/2
- NEXT Oncology Virginia, Fairfax · на 11 милји
A Study of LY4175408 in Participants With Advanced Cancer
Се регрутираФаза 1
- NEXT Virginia, Fairfax · на 11 милји
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
Се регрутираФаза 1
- Virginia Cancer Specialists - Fairfax /ID# 232592, Fairfax · на 11 милји
Study of XB010 in Subjects With Solid Tumors
Се регрутираФаза 1
- Inova Schar Cancer, Fairfax · на 11 милји
- NEXT Virginia, Fairfax · на 11 милји
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
Се регрутираФаза 1
- NEXT Texas LLC - Virginia, Fairfax · на 11 милји
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
Се регрутираФаза 1
- NEXT Virginia, Fairfax · на 11 милји
First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
Се регрутираФаза 1
- Research Site, Fairfax · на 11 милји
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Се регрутираФаза 1
- Research Site, Fairfax · на 11 милји
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Се регрутираФаза 2
- Kaiser Permanente Tysons Corner Medical Center, McLean · на 5 милји
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Се регрутираФаза 1
- NEXT Oncology Virginia, Fairfax · на 11 милји
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
Се регрутираФаза 1/2
- NEXT Virginia, Fairfax · на 11 милји
Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)
Се регрутираФаза 3
- Virginia Cancer Specialists, Fairfax · на 11 милји
Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 mAb, Administered Alone and in Combination With a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study)
Се регрутираФаза 1/2
- NEXT Oncology, Fairfax · на 11 милји
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Се регрутираФаза 1
- NEXT Oncology Virginia, Fairfax · на 11 милји
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Се регрутираФаза 1/2
- Next Oncology Virginia, Fairfax · на 11 милји
A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Се регрутираФаза 3
- Research Site, Fairfax · на 11 милји
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Се регрутираФаза 2/3
- Kaiser Permanente Tysons Corner Medical Center, McLean · на 5 милји
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Се регрутираФаза 2
- Kaiser Permanente Tysons Corner Medical Center, McLean · на 5 милји
A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung Adenocarcinoma
Се регрутираФаза 2
- Inova Fairfax Hospital, Fairfax · на 11 милји
A 2-part Phase 1/2 Open-label Trial on ODM-212
Се регрутираФаза 1/2
- NEXT Oncology Virginia, Fairfax · на 11 милји
A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
Се регрутираФаза 1/2
- NEXT Virginia, Fairfax · на 11 милји
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Се регрутираФаза 1/2
- Virginia Cancer Specialists, Fairfax · на 11 милји
Phase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLC
Се регрутираФаза 1
- Research Site, Fairfax · на 11 милји
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
Се регрутираФаза 1/2
- NEXT Virginia, Fairfax · на 11 милји
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
Се регрутираФаза 1/2
- NEXT Virginia, Fairfax · на 11 милји
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
Се регрутираФаза 1
- NEXT Virginia, Fairfax · на 11 милји
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
Се регрутираФаза 1/2
- Virginia Cancer Specialists, Fairfax · на 11 милји
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Се регрутираФаза 1/2
- NEXT Virginia, Fairfax · на 11 милји
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
Се регрутираФаза 1/2
- NEXT, Virginia, Fairfax · на 11 милји
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
Се регрутираФаза 1
- Dren Investigational Site, Fairfax · на 11 милји
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
Се регрутираФаза 1
- Virginia Cancer Specialists, Fairfax · на 11 милји
Study to Evaluate LB-LR1109, Administered Alone for the Treatment of Solid Tumor and in Combination With Atezolizumab for the Treatment of NSCLC
Се регрутираФаза 1
- NEXT Oncology, Fairfax · на 11 милји
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Се регрутираФаза 1/2
- Research Site 102, Fairfax · на 11 милји
- Research Site 112, Fairfax · на 11 милји
A Study to Assess the Efficacy of WSD0922-FU in Patients With C797S+ Advanced Non-small Cell Lung Cancer
Се регрутираФаза 2
- Virginia Cancer Specialists, Fairfax · на 11 милји
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
Се регрутираФаза 1/2
- Virginia Cancer Specialists, Fairfax · на 11 милји
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
Се регрутираФаза 1/2
- NEXT Virginia, Fairfax · на 11 милји
Испитувања за Рак на бели дробови со не-мали клетки во други градови
- Houston, TX145 студии
- New York City, NY121 студија
- Nashville, TN97 студии
- Boston, MA90 студии
- Los Angeles, CA87 студии
- St. Louis, MO73 студии
- Chicago, IL61 студија
- Baltimore, MD60 студии
- San Antonio, TX59 студии
- Columbus, OH57 студии
- Washington, DC55 студии
- Seattle, WA53 студии
Други студии во Arlington
- Метастатски карцином53 студии
- Колоректален карцином52 студии
- Рак (сите типови)48 студии
- Рак на дојка47 студии
- Карцином на јајниците46 студии
- Рак на бели дробови41 студија
- Рак на ендометриумот39 студии
- Карцином на панкреасот33 студии
- Сквамозноклеточен карцином на глава и врат26 студии
- Малоклеточен рак на бели дробови23 студии
- Рак на стомакот20 студии
- Трипл негативен рак на дојка20 студии
Од ClinicalTrials.gov, податоци преземени 6.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.